Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leukemia × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Vomiting 5 Neoplasms 3 Nausea 2 Lymphoma 1 Leukemia 1 Breast Neoplasms 1

Interventions

nilotinib 4 Cytarabine 3 Filgrastim 2 Cyclophosphamide 2 Aprepitant 2 Antilymphocyte Serum 2 rasburicase 1 fludarabine phosphate 1 fludarabine 1 bosutinib 1 blinatumomab 1 aldesleukin 1 Water 1 Voriconazole 1 Urate Oxidase 1 Tobacco Use Cessation Devices 1 Thiotepa 1 Rituximab 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Prilocaine 1 Polymerase Chain Reaction 1 Pharmacogenomic Testing 1 Pentostatin 1 Palonosetron 1 Oxygen 1 Interleukin-2 1 Inotuzumab Ozogamicin 1 Histamine 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡